MPM BioVentures 2014, L.P. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-09 8:23 pm Sale |
2021-12-06 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 4,730,197 13.400% |
-407,017 (-7.92%) |
Filing |
| 2021-10-19 4:06 pm Sale |
2021-10-13 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 5,137,214 14.600% |
-438,998 (-7.87%) |
Filing |
| 2021-09-21 4:32 pm Sale |
2021-09-16 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 5,576,212 13.000% |
-486,008 (-8.02%) |
Filing |
| 2020-08-07 5:42 pm Purchase |
2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS |
MPM BioVentures 2014, L.P. | 6,062,220 18.100% |
6,062,220 (New Position) |
Filing |